Three Months Ended | Nine Months Ended | ||||||||||||||||||
December 31, | December 31, | ||||||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||||||
Research and development expenses, as reported | $ | 210.1 | $ | 217.1 | $ | 607.9 | $ | 656.0 | |||||||||||
Share-based compensation expense | (25.0 | ) | (21.2 | ) | (70.0 | ) | (63.0 | ) | |||||||||||
Acquisition-related | (0.2 | ) | — | (0.2 | ) | (0.1 | ) | ||||||||||||
Non-GAAP research and development expenses | $ | 184.9 | $ | 195.9 | $ | 537.7 | $ | 592.9 | |||||||||||
Non-GAAP research and development expenses as a percentage of net sales | 13.7 | % | 15.2 | % | 13.5 | % | 15.0 | % | |||||||||||
Microchip Technology Announces Financial Results for Third Quarter of Fiscal Year 2021
| | More IC News |
|
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES
RELATED NEWS